European Medicines Agency (EMA) with the European Commission; national competent authorities in each member state
Is Retatrutide legal in European Union?
Not approvedInvestigational; no EU marketing authorisation and no application under evaluation
Not approved as a medicine here.
Retatrutide is not in the Union Register and is absent from EMA's September 2026 list of applications under evaluation, so no EU authorisation exists and none is under formal review. Under Article 6 of Directive 2001/83/EC, no medicine may be placed on the market without a marketing authorisation. Products sold online under this name are unauthorised and not covered by any EU quality checks.
Last verified 2026-09-29 · how we verify
Retatrutide elsewhere
Sources (3)
- 01Union Register of medicinal products for human useEuropean Commission · 2026-09-29 · accessed 2026-09-29
- 02Applications for new human medicines under evaluation by the CHMP (September 2026)European Medicines Agency · 2026-09-04 · accessed 2026-09-29
- 03Directive 2001/83/EC on the Community code relating to medicinal products for human use (consolidated text, 1 January 2025)European Union (EUR-Lex) · 2025-01-01 · accessed 2026-09-29